Publication:
Comparison of Efficacy and Persistence of First Line Fingolimod vs Interferon-Beta/Glatiramer in the Presence of Prior Disease Activity

dc.contributor.authorSpelman, T.
dc.contributor.authorIzquierdo, G.
dc.contributor.authorAlroughani, R.
dc.contributor.authorFernandez Bolaos, R.
dc.contributor.authorHavrdova, E.
dc.contributor.authorHoraova, D.
dc.contributor.authorButzkueven, H.
dc.contributor.authorIDLugaresi, Alessandra/0000-0003-2902-5589
dc.contributor.authorIDSlee, Mark/0000-0003-4323-2453
dc.contributor.authorIDOreja-Guevara, Celia/0000-0002-9221-5716
dc.contributor.authorIDHavrdova, Eva Kubala/0000-0002-9543-4359
dc.date.accessioned2020-06-21T13:45:28Z
dc.date.available2020-06-21T13:45:28Z
dc.date.issued2015
dc.departmentOMÜen_US
dc.department-temp[Spelman, T. -- Butzkueven, H.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia -- [Izquierdo, G.] Hosp Univ Virgen Macarena, Seville, Spain -- [Alroughani, R.] Amiri Hosp, Kuwait, Kuwait -- [Fernandez Bolaos, R.] Hosp Univ Virgen de Valme, Seville, Spain -- [Havrdova, E.] Charles Univ Prague, Hosp Kralovske Vinohrady, Fac Med 3, Prague, Czech Republic -- [Horaova, D.] Charles Univ Prague, Prague, Czech Republicen_US
dc.description31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- OCT 07-10, 2015 -- Barcelona, SPAINen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.identifier.endpage238en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage237en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14089
dc.identifier.volume21en_US
dc.identifier.wosWOS:000365729400421
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparison of Efficacy and Persistence of First Line Fingolimod vs Interferon-Beta/Glatiramer in the Presence of Prior Disease Activityen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files